Paul Alan Berkowitz, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Drive, Suite 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 Fax: 734-712-2935 |
Paul Gordon Smith, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5333 Mcauley Drive, Suite 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 Fax: 734-712-2935 |
Eric Andrew Dancey, M.D. Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Drive, Suite 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 Fax: 734-712-2935 |
Judith Michelle Mayer, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Drive, Suite 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 Fax: 734-712-2935 |
Dr. Rakesh Kanipakam, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr Rm 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 |
Jariatul Karim, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Ste 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 Fax: 734-712-2935 |
Dr. Sushma N Pandrangi, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 Fax: 734-712-2935 |
Javeria Farook Syed, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr Rm 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 Fax: 734-712-2935 |
George Michael Behrend, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Drive, Suite 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 Fax: 734-712-2935 |
Dr. Ahmad Bilal Masood, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr Rm 4003, Ypsilanti, MI 48197 Phone: 734-712-3470 Fax: 734-712-2935 |
News Archive
One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.
Unless new treatments are found, it is predicted that more than 100 million people worldwide will be affected by Alzheimer's disease by 2050. With very few new drugs in the pipeline, researchers are exploring every possible avenue to treat the disease.
The fate of the Affordable Care Act is again on the line Tuesday, as a federal appeals court in New Orleans takes up a case in which a lower court judge has already ruled the massive health law unconstitutional.
Emergent BioSolutions Inc. announced today it has entered into a definitive agreement to acquire Trubion Pharmaceuticals, Inc. for upfront consideration of $96.8 million of value and up to $38.7 million of success-based milestones, resulting in a total consideration of up to $135.5 million. The acquisition will diversify Emergent's product development pipeline with the addition of Trubion's two clinical-stage product candidates focused on the targeted disease areas of oncology and autoimmunity.
› Verified 5 days ago